VIATREXX-ADIPOSE- epinephrine , artery , metenkefalin , adenosine triphosphate , adenosine cyclic phosphate , centella asiatica

Pays: États-Unis

Langue: anglais

Source: NLM (National Library of Medicine)

Achète-le

Ingrédients actifs:

Epinephrine (UNII: YKH834O4BH) (Epinephrine - UNII:YKH834O4BH), Bos Taurus Artery (UNII: R2M88A4HSI) (Bos Taurus Artery - UNII:R2M88A4HSI), Sus Scrofa Artery (UNII: 63O327782Q) (Sus Scrofa Artery - UNII:63O327782Q), Adenosine Triphosphate (UNII: 8L70Q75FXE) (Adenosine Triphosphate - UNII:8L70Q75FXE), Adenosine Cyclic Phosphate (UNII: E0399OZS9N) (Adenosine Cyclic Phosphate - UNII:E0399OZS9N), Centella Asiatica (UNII: 7M867G6T1U) (Centella Asiatica - UNII:7M867G6T1U), Citric Acid Monohydrate (UNII: 2968PHW8Q

Disponible depuis:

VIATREXX BIO INCORPORATED

Mode d'administration:

INTRAVENOUS

Type d'ordonnance:

PRESCRIPTION DRUG

indications thérapeutiques:

Viatrexx-Adipose  a sterile, injectable, biodegradable, clear isotonic liquid that is injected into the various layers of the skin, muscles, ligaments, joints, other body tissues or added to an IV, either as a push or into the bag. This product should not be used in patients with a known hypersensitivity to any ingredient found in the formula, porcine products, isotonic saline or benzyl alcohol, or patients with a history of severe allergies. As with all injections, epinephrine injection (1:1,000) must be immediately available should an acute anaphylactoid reaction occur due to any component of the injection. This product contains 1% Benzyl Alcohol. Benzyl Alcohol has been reported to be associated with a fatal "Gasping Syndrome" in premature infants. Due to the benzyl alcohol content, this product should not be given to a pregnant woman. This product should not be used in patients with a known hypersensitivity to any ingredient in this formula, porcine products, isotonic saline or benzyl alcohol, or patients

Statut de autorisation:

unapproved drug other

Résumé des caractéristiques du produit

                                VIATREXX-ADIPOSE- EPINEPHRINE , ARTERY , METENKEFALIN , ADENOSINE
TRIPHOSPHATE , ADENOSINE
CYCLIC PHOSPHATE , CENTELLA ASIATICA , CITRIC ACID MONOHYDRATE ,
COENZYME A , COLCHICUM AUTUMNALE
BULB , FUMARIC ACID , INTERLEUKIN-10 , LEVOCARNITINE , LACTIC ACID ,
PANCRELIPASE LIPASE , LIVER , LYMPH,
SODIUM DIETHYL OXALACETATE , SODIUM PYRUVATE , PITUITARY GLAND,
QUINHYDRONE , SUCCINIC ACID ,
PARATHYROID GLAND, VEIN, YOHIMBINE, FERROUS FUMARATE, MECASERMIN,
POTASSIUM ASPARTATE AND
MOMORDICA BALSAMINA WHOLE INJECTION
VIATREXX BIO INCORPORATED
_Disclaimer: This drug has not been found by FDA to be safe and
effective, and this labeling has not been_
_approved by FDA. For further information about unapproved drugs,
click here._
----------
ADIPOS E
10ml
Rx
Sterile multi-dose injectable homeopathic vial
Isotonic saline with 1% Benzyl alcohol as a preservative.
For IV, IM, SC, Parenteral Use
Osmolarity around 0.3mOsmol/ml.
DES CRIPTION
VIATREXX-ADIPOSE is a homeopathic product composed of physiological
(low dose and low low dose)
natural micro nutrients. These nano particles are designed to nourish
the system.
INDICATIONS AND USE
VIATREXX-ADIPOSE a sterile, injectable, biodegradable, clear isotonic
liquid that is injected into the
various layers of the skin, muscles, ligaments, joints, other body
tissues or added to an IV, either as a
push or into the bag.
CONTRAINDICATIONS
This product should not be used in patients with a known
hypersensitivity to any ingredient found in the
formula, porcine products, isotonic saline or benzyl alcohol, or
patients with a history of severe
allergies. As with all injections, epinephrine injection (1:1,000)
must be immediately available should an
acute anaphylactoid reaction occur due to any component of the
injection.
WARNINGS
Homeopathic injections are quite safe, but all medical procedures
carry some risk. The most common
risk is an allergic reaction to the injection of any ingredient found
in the formula, porcine, benzyl
alcohol &/or saline. Do not use if allergic to any of these
substances
                                
                                Lire le document complet